David B Seifer, Geralyn Lambert-Messerlian, Glenn E Palomaki, Robert M Silver, Corette Parker, Carol J Rowland Hogue, Barbara J Stoll, George R Saade, Robert L Goldenberg, Donald J Dudley, Radek Bukowski, Halit Pinar, Uma M Reddy
{"title":"分娩时子痫前期与血清维生素D降低和抗血管生成因子升高有关:一项病例对照研究。","authors":"David B Seifer, Geralyn Lambert-Messerlian, Glenn E Palomaki, Robert M Silver, Corette Parker, Carol J Rowland Hogue, Barbara J Stoll, George R Saade, Robert L Goldenberg, Donald J Dudley, Radek Bukowski, Halit Pinar, Uma M Reddy","doi":"10.1186/s12958-021-00885-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Preeclampsia is characterized by decreased trophoblastic angiogenesis leading to abnormal invasion of spiral arteries, shallow implantation and resulting in compromised placentation with poor uteroplacental perfusion. Vitamin D plays an important role in pregnancy influencing implantation, angiogenesis and placental development. The objective of this study was to determine whether there is an association between serum vitamin D levels, and anti-angiogenic factors at the time of delivery and the occurrence of preeclampsia.</p><p><strong>Methods: </strong>This nested case control study analyzed frozen serum samples at the time of delivery and related clinical data from women with singleton liveborn pregnancies who had participated in studies of the NICHD Stillbirth Collaborative Research Network. Women with a recorded finding of preeclampsia and who had received magnesium sulfate treatment prior to delivery were considered index cases (N = 56). Women without a finding of preeclampsia were controls (N = 341).</p><p><strong>Results: </strong>Women with preeclampsia had 14.5% lower serum vitamin D levels than women in the control group (16.5 ng/ml vs. 19 ng/ml, p = 0.014) with 64.5% higher sFlt-1 levels (11,600 pg/ml vs. 7050 pg/ml, p < 0.001) and greater than 2 times higher endoglin levels (18.6 ng/ml vs. 8.7 ng/ml, < 0.001). After controlling for gestational age at delivery and maternal BMI, vitamin D levels were 0.88 times lower (P = 0.051), while endoglin levels were 2.5 times higher and sFlt-1 levels were 2.1 times higher than in control pregnancies (P < 0.001).</p><p><strong>Conclusions: </strong>Women with preeclampsia at time of delivery have higher maternal antiangiogenetic factors and may have lower maternal serum vitamin D levels. These findings may lead to a better understanding of the underlying etiology of preeclampsia as well as possible modifiable treatment options which could include assuring adequate levels of maternal serum vitamin D prior to pregnancy.</p>","PeriodicalId":520764,"journal":{"name":"Reproductive biology and endocrinology : RB&E","volume":" ","pages":"8"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734360/pdf/","citationCount":"2","resultStr":"{\"title\":\"Preeclampsia at delivery is associated with lower serum vitamin D and higher antiangiogenic factors: a case control study.\",\"authors\":\"David B Seifer, Geralyn Lambert-Messerlian, Glenn E Palomaki, Robert M Silver, Corette Parker, Carol J Rowland Hogue, Barbara J Stoll, George R Saade, Robert L Goldenberg, Donald J Dudley, Radek Bukowski, Halit Pinar, Uma M Reddy\",\"doi\":\"10.1186/s12958-021-00885-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Preeclampsia is characterized by decreased trophoblastic angiogenesis leading to abnormal invasion of spiral arteries, shallow implantation and resulting in compromised placentation with poor uteroplacental perfusion. Vitamin D plays an important role in pregnancy influencing implantation, angiogenesis and placental development. The objective of this study was to determine whether there is an association between serum vitamin D levels, and anti-angiogenic factors at the time of delivery and the occurrence of preeclampsia.</p><p><strong>Methods: </strong>This nested case control study analyzed frozen serum samples at the time of delivery and related clinical data from women with singleton liveborn pregnancies who had participated in studies of the NICHD Stillbirth Collaborative Research Network. Women with a recorded finding of preeclampsia and who had received magnesium sulfate treatment prior to delivery were considered index cases (N = 56). Women without a finding of preeclampsia were controls (N = 341).</p><p><strong>Results: </strong>Women with preeclampsia had 14.5% lower serum vitamin D levels than women in the control group (16.5 ng/ml vs. 19 ng/ml, p = 0.014) with 64.5% higher sFlt-1 levels (11,600 pg/ml vs. 7050 pg/ml, p < 0.001) and greater than 2 times higher endoglin levels (18.6 ng/ml vs. 8.7 ng/ml, < 0.001). After controlling for gestational age at delivery and maternal BMI, vitamin D levels were 0.88 times lower (P = 0.051), while endoglin levels were 2.5 times higher and sFlt-1 levels were 2.1 times higher than in control pregnancies (P < 0.001).</p><p><strong>Conclusions: </strong>Women with preeclampsia at time of delivery have higher maternal antiangiogenetic factors and may have lower maternal serum vitamin D levels. These findings may lead to a better understanding of the underlying etiology of preeclampsia as well as possible modifiable treatment options which could include assuring adequate levels of maternal serum vitamin D prior to pregnancy.</p>\",\"PeriodicalId\":520764,\"journal\":{\"name\":\"Reproductive biology and endocrinology : RB&E\",\"volume\":\" \",\"pages\":\"8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734360/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproductive biology and endocrinology : RB&E\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12958-021-00885-z\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive biology and endocrinology : RB&E","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12958-021-00885-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
摘要
背景:子痫前期的特点是滋养层血管生成减少,导致螺旋动脉异常侵入,植入浅,导致胎盘受损,子宫胎盘灌注不良。维生素D在妊娠中对着床、血管生成和胎盘发育起重要作用。本研究的目的是确定分娩时血清维生素D水平和抗血管生成因子与子痫前期发生之间是否存在关联。方法:本巢式病例对照研究分析了参加NICHD死产合作研究网络研究的单胎活产妊娠妇女分娩时的冷冻血清样本和相关临床数据。有记录的先兆子痫和分娩前接受硫酸镁治疗的妇女被认为是指标病例(N = 56)。对照组为未发现子痫前期的妇女(N = 341)。结果:子痫前期妇女血清维生素D水平比对照组低14.5% (16.5 ng/ml vs. 19 ng/ml, p = 0.014), sFlt-1水平高64.5% (11,600 pg/ml vs. 7050 pg/ml, p)。结论:子痫前期妇女分娩时母体抗血管生成因子较高,可能母体血清维生素D水平较低。这些发现可能有助于更好地了解先兆子痫的潜在病因,以及可能修改的治疗方案,包括在怀孕前确保母体血清维生素D的足够水平。
Preeclampsia at delivery is associated with lower serum vitamin D and higher antiangiogenic factors: a case control study.
Background: Preeclampsia is characterized by decreased trophoblastic angiogenesis leading to abnormal invasion of spiral arteries, shallow implantation and resulting in compromised placentation with poor uteroplacental perfusion. Vitamin D plays an important role in pregnancy influencing implantation, angiogenesis and placental development. The objective of this study was to determine whether there is an association between serum vitamin D levels, and anti-angiogenic factors at the time of delivery and the occurrence of preeclampsia.
Methods: This nested case control study analyzed frozen serum samples at the time of delivery and related clinical data from women with singleton liveborn pregnancies who had participated in studies of the NICHD Stillbirth Collaborative Research Network. Women with a recorded finding of preeclampsia and who had received magnesium sulfate treatment prior to delivery were considered index cases (N = 56). Women without a finding of preeclampsia were controls (N = 341).
Results: Women with preeclampsia had 14.5% lower serum vitamin D levels than women in the control group (16.5 ng/ml vs. 19 ng/ml, p = 0.014) with 64.5% higher sFlt-1 levels (11,600 pg/ml vs. 7050 pg/ml, p < 0.001) and greater than 2 times higher endoglin levels (18.6 ng/ml vs. 8.7 ng/ml, < 0.001). After controlling for gestational age at delivery and maternal BMI, vitamin D levels were 0.88 times lower (P = 0.051), while endoglin levels were 2.5 times higher and sFlt-1 levels were 2.1 times higher than in control pregnancies (P < 0.001).
Conclusions: Women with preeclampsia at time of delivery have higher maternal antiangiogenetic factors and may have lower maternal serum vitamin D levels. These findings may lead to a better understanding of the underlying etiology of preeclampsia as well as possible modifiable treatment options which could include assuring adequate levels of maternal serum vitamin D prior to pregnancy.